Despite this strong mechanistic rationale, no systematic investigation has examined the molecular synergistic interactions between ALA and metformin specifically in diabetic encephalopathy, particularly regarding their convergent effects on Nrf2-AMPK pathway cross-talk and the resulting functional cognitive outcomes. Here, NFE2L2 is linked to diabetic encephalopathy.